Pharmacological modulation of prostaglandin E2 (PGE2) EP receptors improves cardiomyocyte function u...
Pharmacological modulation of prostaglandin E2 (PGE2) EP receptors improves cardiomyocyte function under hyperglycemic conditions
About this item
Full title
Author / Creator
Publisher
Oxford: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Type 2 diabetes (T2D) affects >30 million Americans and nearly 70% of individuals with T2D will die from cardiovascular disease (CVD). Circulating levels of the inflammatory signaling lipid, prostaglandin E2 (PGE2), are elevated in the setting of obesity and T2D and are associated with decreased cardiac function. The EP3 and EP4 PGE2 receptors have...
Alternative Titles
Full title
Pharmacological modulation of prostaglandin E2 (PGE2) EP receptors improves cardiomyocyte function under hyperglycemic conditions
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6833e123a5be47539795aa50463c9b99
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6833e123a5be47539795aa50463c9b99
Other Identifiers
ISSN
2051-817X
E-ISSN
2051-817X
DOI
10.14814/phy2.15212
